DK0507852T3 - Gen deleteret hos mennesker med kolorektal cancer - Google Patents
Gen deleteret hos mennesker med kolorektal cancerInfo
- Publication number
- DK0507852T3 DK0507852T3 DK91902391T DK91902391T DK0507852T3 DK 0507852 T3 DK0507852 T3 DK 0507852T3 DK 91902391 T DK91902391 T DK 91902391T DK 91902391 T DK91902391 T DK 91902391T DK 0507852 T3 DK0507852 T3 DK 0507852T3
- Authority
- DK
- Denmark
- Prior art keywords
- dcc
- people
- colorectal cancer
- gene
- gene deleted
- Prior art date
Links
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 206010009944 Colon cancer Diseases 0.000 title 1
- 108700025699 DCC Genes Proteins 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000003292 diminished effect Effects 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46098190A | 1990-01-04 | 1990-01-04 | |
PCT/US1990/007314 WO1991009964A1 (en) | 1990-01-04 | 1990-12-19 | Gene deleted in colorectal cancer of humans |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0507852T3 true DK0507852T3 (da) | 1999-01-04 |
Family
ID=23830791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91902391T DK0507852T3 (da) | 1990-01-04 | 1990-12-19 | Gen deleteret hos mennesker med kolorektal cancer |
Country Status (10)
Country | Link |
---|---|
US (5) | US5532108A (da) |
EP (1) | EP0507852B1 (da) |
JP (1) | JPH05508307A (da) |
AT (1) | ATE164629T1 (da) |
AU (1) | AU649431B2 (da) |
CA (1) | CA2073186C (da) |
DE (1) | DE69032209T2 (da) |
DK (1) | DK0507852T3 (da) |
ES (1) | ES2115611T3 (da) |
WO (1) | WO1991009964A1 (da) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9201929D0 (sv) * | 1992-06-23 | 1992-06-23 | Pharmacia Lkb Biotech | Method and system for molecular-biological diagnostics |
JP3151054B2 (ja) * | 1992-06-25 | 2001-04-03 | 協和醗酵工業株式会社 | 抗dcc遺伝子産物モノクローナル抗体 |
WO1994020616A1 (en) * | 1993-03-05 | 1994-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas |
EP0700446A1 (en) * | 1993-05-26 | 1996-03-13 | The Johns Hopkins University | Antibodies specific for dcc gene product |
US5709998A (en) * | 1993-12-15 | 1998-01-20 | The Johns Hopkins University | Molecular diagnosis of familial adenomatous polyposis |
CH686982A5 (fr) * | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
US5747282A (en) * | 1994-08-12 | 1998-05-05 | Myraid Genetics, Inc. | 17Q-linked breast and ovarian cancer susceptibility gene |
US5693473A (en) * | 1994-08-12 | 1997-12-02 | Myriad Genetics, Inc. | Linked breast and ovarian cancer susceptibility gene |
US5709999A (en) * | 1994-08-12 | 1998-01-20 | Myriad Genetics Inc. | Linked breast and ovarian cancer susceptibility gene |
ES2164136T5 (es) * | 1994-08-12 | 2009-02-16 | The University Of Utah Research Foundation | Sondas de acidos nucleicos que copmrenden un fragmento del gen de susceptibilidad al cancer de mama y ovarios asociado a 17q. |
US5753441A (en) * | 1994-08-12 | 1998-05-19 | Myriad Genetics, Inc. | 170-linked breast and ovarian cancer susceptibility gene |
US5702886A (en) * | 1994-10-05 | 1997-12-30 | The Johns Hopkins University | Chromosome I8Q loss and prognosis in colorectal cancer |
US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5891629A (en) * | 1995-09-28 | 1999-04-06 | Ambion, Inc. | Compositions for improving RNase cleavage of base pair mismatches in double-stranded nucleic acids |
GB9518156D0 (en) * | 1995-09-06 | 1995-11-08 | Medical Res Council | Method of isolating cells |
US5670325A (en) * | 1996-08-14 | 1997-09-23 | Exact Laboratories, Inc. | Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample |
US5741650A (en) * | 1996-01-30 | 1998-04-21 | Exact Laboratories, Inc. | Methods for detecting colon cancer from stool samples |
EP1291657A3 (en) * | 1996-01-30 | 2003-08-27 | Exact Sciences Corporation | Methods for detecting colon cancer from stool samples |
CA2252617A1 (en) * | 1996-05-01 | 1997-11-06 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5858665A (en) * | 1996-07-25 | 1999-01-12 | Navix, Inc. | Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification |
US5928870A (en) * | 1997-06-16 | 1999-07-27 | Exact Laboratories, Inc. | Methods for the detection of loss of heterozygosity |
US6146828A (en) * | 1996-08-14 | 2000-11-14 | Exact Laboratories, Inc. | Methods for detecting differences in RNA expression levels and uses therefor |
US6020137A (en) * | 1996-08-14 | 2000-02-01 | Exact Laboratories, Inc. | Methods for the detection of loss of heterozygosity |
US6300077B1 (en) | 1996-08-14 | 2001-10-09 | Exact Sciences Corporation | Methods for the detection of nucleic acids |
US6203993B1 (en) | 1996-08-14 | 2001-03-20 | Exact Science Corp. | Methods for the detection of nucleic acids |
US6100029A (en) * | 1996-08-14 | 2000-08-08 | Exact Laboratories, Inc. | Methods for the detection of chromosomal aberrations |
US5830665A (en) * | 1997-03-03 | 1998-11-03 | Exact Laboratories, Inc. | Contiguous genomic sequence scanning |
US6406857B1 (en) | 1997-06-16 | 2002-06-18 | Exact Sciences Corporation | Methods for stool sample preparation |
US6268136B1 (en) | 1997-06-16 | 2001-07-31 | Exact Science Corporation | Methods for stool sample preparation |
US20020064792A1 (en) * | 1997-11-13 | 2002-05-30 | Lincoln Stephen E. | Database for storage and analysis of full-length sequences |
US6280947B1 (en) | 1999-08-11 | 2001-08-28 | Exact Sciences Corporation | Methods for detecting nucleotide insertion or deletion using primer extension |
US6503718B2 (en) | 1999-01-10 | 2003-01-07 | Exact Sciences Corporation | Methods for detecting mutations using primer extension for detecting disease |
US7148016B1 (en) | 1999-01-14 | 2006-12-12 | Ca*Tx Inc. | Immunoassays to detect diseases or disease susceptibility traits |
WO2000042436A1 (en) * | 1999-01-14 | 2000-07-20 | Ca*Tx, Inc. | Immunoassays to detect diseases or disease susceptibility traits |
ES2269102T3 (es) | 1999-02-25 | 2007-04-01 | Exact Sciences Corporation | Procedimientos para conservar la integridad del adn. |
JP4794052B2 (ja) * | 1999-04-09 | 2011-10-12 | ジェンザイム・コーポレーション | 癌の指標である核酸を検出するための方法 |
US6586177B1 (en) * | 1999-09-08 | 2003-07-01 | Exact Sciences Corporation | Methods for disease detection |
US6849403B1 (en) | 1999-09-08 | 2005-02-01 | Exact Sciences Corporation | Apparatus and method for drug screening |
US6919174B1 (en) * | 1999-12-07 | 2005-07-19 | Exact Sciences Corporation | Methods for disease detection |
US7368233B2 (en) * | 1999-12-07 | 2008-05-06 | Exact Sciences Corporation | Methods of screening for lung neoplasm based on stool samples containing a nucleic acid marker indicative of a neoplasm |
AU2001260116A1 (en) * | 2000-03-14 | 2001-09-24 | Bayer Aktiengesellschaft | Human dcc-like proteins |
US6492120B1 (en) | 2000-11-02 | 2002-12-10 | University Of Maryland | Nucleic acid hybridization assay utilizing tricyclic target and signal amplification |
US6428964B1 (en) | 2001-03-15 | 2002-08-06 | Exact Sciences Corporation | Method for alteration detection |
WO2003035902A2 (en) * | 2001-10-25 | 2003-05-01 | The Hospital For Sick Children | Method for williams-beuren syndrome diagnosis |
AU2003213107A1 (en) * | 2002-02-15 | 2003-09-09 | Exact Sciences Corporation | Methods for analysis of molecular events |
US20050074793A1 (en) * | 2003-04-04 | 2005-04-07 | Wilson Keith E. | Metastatic colorectal cancer signatures |
US20040259101A1 (en) * | 2003-06-20 | 2004-12-23 | Shuber Anthony P. | Methods for disease screening |
JP2007512509A (ja) * | 2003-11-05 | 2007-05-17 | エグザクト サイエンシーズ コーポレイション | 反復的親和性分離およびその使用 |
WO2005111244A2 (en) * | 2004-05-10 | 2005-11-24 | Exact Sciences Corporation | Methods for detecting a mutant nucleic acid |
WO2005113769A1 (en) * | 2004-05-14 | 2005-12-01 | Exact Sciences Corporation | Method for stabilizing biological samples for nucleic acid analysis |
US7981607B2 (en) * | 2004-08-27 | 2011-07-19 | Esoterix Genetic Laboratories LLC | Method for detecting recombinant event |
WO2006047787A2 (en) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Method for monitoring disease progression or recurrence |
ES2313143T3 (es) | 2005-04-06 | 2009-03-01 | Maurice Stroun | Metodo para el diagnostico de cancer mediante la deteccion de adn y arn circulantes. |
WO2007044071A2 (en) | 2005-04-21 | 2007-04-19 | Exact Sciences Corporation | Analysis of heterogeneous nucleic acid samples |
EP2971091A1 (en) | 2013-03-14 | 2016-01-20 | Abbott Molecular Inc. | Materials and methods for assessment of colorectal adenoma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4831124A (en) * | 1980-12-10 | 1989-05-16 | Research Corporation Technologies | Recombinant cDNA construction method and hybrid nucleotides useful in cloning |
US5380645A (en) * | 1989-03-16 | 1995-01-10 | The Johns Hopkins University | Generalized method for assessment of colorectal carcinoma |
US5043272A (en) * | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
JP3151054B2 (ja) * | 1992-06-25 | 2001-04-03 | 協和醗酵工業株式会社 | 抗dcc遺伝子産物モノクローナル抗体 |
-
1990
- 1990-12-19 AU AU71585/91A patent/AU649431B2/en not_active Ceased
- 1990-12-19 JP JP3502772A patent/JPH05508307A/ja active Pending
- 1990-12-19 WO PCT/US1990/007314 patent/WO1991009964A1/en active IP Right Grant
- 1990-12-19 ES ES91902391T patent/ES2115611T3/es not_active Expired - Lifetime
- 1990-12-19 CA CA002073186A patent/CA2073186C/en not_active Expired - Fee Related
- 1990-12-19 AT AT91902391T patent/ATE164629T1/de not_active IP Right Cessation
- 1990-12-19 DK DK91902391T patent/DK0507852T3/da active
- 1990-12-19 EP EP91902391A patent/EP0507852B1/en not_active Expired - Lifetime
- 1990-12-19 DE DE69032209T patent/DE69032209T2/de not_active Expired - Fee Related
-
1994
- 1994-04-14 US US08/227,527 patent/US5532108A/en not_active Expired - Lifetime
-
1995
- 1995-05-17 US US08/442,761 patent/US5602243A/en not_active Expired - Lifetime
- 1995-05-17 US US08/443,360 patent/US5650281A/en not_active Expired - Lifetime
- 1995-05-17 US US08/442,977 patent/US5874545A/en not_active Expired - Lifetime
- 1995-05-17 US US08/442,976 patent/US5561223A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69032209T2 (de) | 1998-12-03 |
US5561223A (en) | 1996-10-01 |
CA2073186C (en) | 2002-06-11 |
WO1991009964A1 (en) | 1991-07-11 |
CA2073186A1 (en) | 1991-07-05 |
US5874545A (en) | 1999-02-23 |
EP0507852B1 (en) | 1998-04-01 |
US5602243A (en) | 1997-02-11 |
US5532108A (en) | 1996-07-02 |
EP0507852A1 (en) | 1992-10-14 |
ES2115611T3 (es) | 1998-07-01 |
DE69032209D1 (de) | 1998-05-07 |
EP0507852A4 (en) | 1993-04-28 |
JPH05508307A (ja) | 1993-11-25 |
ATE164629T1 (de) | 1998-04-15 |
AU649431B2 (en) | 1994-05-26 |
AU7158591A (en) | 1991-07-24 |
US5650281A (en) | 1997-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0507852T3 (da) | Gen deleteret hos mennesker med kolorektal cancer | |
EP0390323A3 (en) | Detection of loss of the wild-type p53 gene | |
ATE194660T1 (de) | Veraendertes gen bei menschlichem colorektalem- krebs | |
DK1013666T3 (da) | Proteinkompleks p53/p90 | |
AU2014899A (en) | Metastatic breast and colon cancer regulated genes | |
PL340057A1 (en) | Determination of cell growth disorders | |
AU2001287639A1 (en) | Trp8, trp9 and trp10, markers for cancer | |
HK1091228A1 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
ATE279212T1 (de) | 2-methoxyestradiol-induzierte apoptosis in krebszellen | |
DK0518650T3 (da) | Sekvensspecifik DNA-binding med p53 | |
CA2164498A1 (en) | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices | |
Olshan et al. | p53 mutations in head and neck cancer: new data and evaluation of mutational spectra. | |
AU6473598A (en) | Method for determining the presence of mutated brca protein | |
Ünal et al. | Prognostic value of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue | |
WO1997022721A3 (en) | Cancer detection probes | |
DK1135513T4 (da) | Adenovirus-medieret genterapi | |
Okada et al. | Metastasizing eccrine sweat gland carcinoma: report of a case | |
Arita et al. | Cutaneous metastasis of prostate carcinoma | |
DE69839846D1 (de) | Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten | |
IT8683362A0 (it) | Procedimento e uso di un colorante naturale rosso ad alta intensita'derivato dalla coltura dei tessuti cellulari di carota. | |
DE68911305D1 (de) | Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen. | |
SU668725A1 (ru) | Сито | |
Vogelstein | DCC probes, primers, and kits | |
SU635271A1 (ru) | Детандер | |
ATE98262T1 (de) | Das lungenwachstum stimulierende und hemmende faktoren fuer krebstumorzellen. |